← Insider buys
GBT

Global Blood Therapeutics, Inc.

Director Mark L Perry sold $4.2M of Global Blood Therapeutics, Inc.

Sold$4,186,061
$78.10Price
53,600Shares
−67%Stake

What GBT did after the filing

Prices for GBT after this filing aren't in yet.

Traded Tue, May 12. Filed Wed, May 13, 2:07 PM ET, during the session. Not investment advice.